|
Volumn 54, Issue 4, 2002, Pages 531-545
|
PEGylated antibodies and antibody fragments for improved therapy: A review
a
UCB PHARMA
(Belgium)
|
Author keywords
Antibody fragment; Fab ; Monoclonal antibody; Pharmacokinetics; Poly(ethylene glycol); Single chain antibodies
|
Indexed keywords
POLYETHYLENE GLYCOLS;
PROTEINS;
TUMORS;
CLINICAL SETTINGS;
ANTIBODIES;
MACROGOL IMMUNOGLOBULIN F(AB')2 FRAGMENT CONJUGATE;
MACROGOL IMMUNOGLOBULIN F(AB) FRAGMENT CONJUGATE;
MONOCLONAL ANTIBODY;
UNCLASSIFIED DRUG;
ANTIGEN BINDING;
DRUG BIOAVAILABILITY;
DRUG HALF LIFE;
DRUG SOLUBILITY;
DRUG STABILITY;
DRUG TARGETING;
HUMAN;
IMMUNE RESPONSE;
IMMUNOGENICITY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN MODIFICATION;
REVIEW;
SOLID TUMOR;
|
EID: 0037124466
PISSN: 0169409X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0169-409X(02)00026-1 Document Type: Article |
Times cited : (508)
|
References (38)
|